Biological Effects of Anti-RANKL Antibody and Zoledronic Acid on Growth and Tooth Eruption in Growing Mice
Work
Year: 2019
Type: article
Abstract: The anti-bone resorptive drugs denosumab, an anti-human-RANKL antibody, and zoledronic acid (ZOL), a nitrogen-containing bisphosphonate, have recently been applied for treatment of pediatric patients ... more
Source: Scientific Reports
Institution Showa University
Cites: 59
Cited by: 15
Related to: 10
FWCI: 0.707
Citation percentile (by year/subfield): 87.85
Topic: Bone health and treatments
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Sustainable Development Goal Good health and well-being
Open Access status: gold
APC paid (est): $2,190